16:00 – 17:00 Welcome Coffee & Registration

FRIDAY | MAY 5 | 17:00 – 19:40

17:00 – 17:20
Introduction: Highlights in Digital Rheumatology 2022/2023
Dr. Johannes Knitza, Prof. Thomas Hügle, Dr. Martin Krusche & Dr. Latika Gupta

17:20 – 17:40
Integrating Patient Reported Outcomes in the Clinical Workflow: Use of a Mobile Health App for RA
Prof. Daniel A. Solomon, Brigham and Women’s Hospital, USA (remote)

17:40 – 18:00
Impact of Telemonitoring in Europe: The EULAR points to consider
Prof. Christian Dejaco, Medical University Graz, Austria (remote)

18:00 – 18:20
Future Care of Spondyloarthritis and Psoriatic Arthritis
Dr. Diego Benavent, Hospital Universitario La Paz, Spain

18:20 – 18:40
How to deploy RA prediction models in practice
Dr. Philip Hamann, North Bristol NHS Trust and University of Bristol, UK

18:40 – 19:00
Decentralized Clinical Trials in Rheumatology

Maya Zlatanova, FindMeCure ltd, UK

19:00 – 19:20
Digital care on prescription to optimize pharmacological outcomes
Prof. Bart van den Bemt, Sint Maartenskliniek Nijmegen, Netherlands

19:20 – 19:40
Discussion round: Evidence and Safety of Digital Health Solutions for Rheumatic Patients

– Networking dinner –

SATURDAY | MAY 6 | 08:30 – 14:30

08:30 – 09:30
Coffee Discussion  | chair: Prof. Jutta Richter

Needs and Expectations of Digital Health from Patients, Private Practices and Industry
Dr. Julie Horan, UCB I Dr. Martin Welcker, MVZ für Rheumatologie I Judith Safford, SCQM I Prof. Sebastian Kuhn, Philipps University Marburg I Matthias Diener, Digital Rheuma Lab

09:30 – 09:50
Presentation Winner of the „Digital Rheumatolology Research Award“

Session I: Publishing in the Future

chairs: Dr. Martin Krusche & Dr. Latika Gupta

09:50 – 10:10
Publishing in the digital future – the end of printed journals and conventional reviewing?
Prof. Gerd Burmester, Charité Berlin, Germany

10:10 – 10:30 
The Impact of ChatGPT and Generative AI on Academic Publishing in Rheumatology
Dr. Emre Bilgin, Hacetteppe University Ankara, Turkey

– coffee break –

Session II: Telemedicine & AI

chairs: Dr. Jacob M. van Laar & Dr. Antoni Chan & Dr. Paco M. J. Welsing

11:00 – 11:20
Remote Monitoring of Axial Spondyloarthritis (ReMonit)
Dr. Inger Jorid Berg, Diakonhejmmet Hospital, Norway

11:20 – 11:40
My Pain Tracker: Digital, remote pain recording and monitoring in children and young people with chronic musculoskeletal pain
Dr. Rebecca Lee, University of Manchester, UK

11:40 – 12:00
Hand motion tracking to monitor disease activity in arthritis
Prof. Vincenzo Venerito, University of Bari, Italy

– lunch break-

Session III: Diagnostic support + DTx

chairs: Prof. Diego Benavent & Dr. Johannes Knitza

13:00 – 13:20
A Digital Diagnostic Decision Support Tool for Individuals Suspecting Rheumatic Diseases: A population based Validation Study
Prof. Rachel Knevel, Leiden University Medical Center, The Netherlands & Newcastle University, UK

13:20 – 13:40
Evaluation of Supported Self-management in Gout (GoutSMART): A Randomised Controlled Feasibility Trial
Dr. Philip Riches, University of Edinburgh Western General Hospital, UK

13:40 – 14:00
DiGAs in Rheumatology Where do we Stand? Real-World-Evidence
Dr. Hannah Labinsky, Erlangen University Hospital, Germany

14:00 – 14:20
Presentation of the winner “Pitching Event for New Digital Solutions”

14:20 -14:30
Closing Remarks

Scientific Advisory Board


Prof. Thomas Hügle

Department of Rheumatology, University Hospital Lausanne, Switzerland

Prof. Jacob M. van Laar

Rheumatology & Clinical Immunology, University Medical Centre Utrecht, Netherlands

Prof. Jutta Richter

Department Rheumatology & Hiller-Research Unit Rheumatology, University Hospital Düsseldorf, Germany

Prof. Didier Hans

Department of Rheumatology, University Hospital Lausanne, Switzerland

Dr. Martin Krusche

Dr. Johannes Knitza

University Hospital Erlangen, Germany

Dr. Martin Krusche

Dr. Martin Krusche

Center of Internal Medicine, University Hospital Hamburg (UKE), Germany

Dr. Johannes Knitza

Dr. Latika Gupta

Royal Wolverhampton Hospitals NHS Trust / University of Manchester, United Kingdom


Dr. Johannes Knitza

Dr. Alexander Oldroyd

University of Manchester, United Kingdom


Dr. Johannes Knitza

Prof. Vincenzo Venerito

University of Bari, Italy


Invited Faculty 


Dr. Inger Jorid Berg

Diakonhjemmet Hospital

Oslo, Norway


Inger Jorid Berg received her medical degree at University of Oslo, Norway in 1996 and is a rheumatologist working at Diakonhjemmet Hospital in Oslo. In 2016 she defended her PhD on a work on ankylosing spondylitis and risk of cardiovascular disease. Now she works part time as a consultant rheumatologist and part time as a post doc researcher in the ReMonit study, which compares digital follow-up, self-monitoring and conventional follow-up of patient with axial spondyloarthritis.

Dr. Emre Bilgin

Hacettepe University

Ankara, Turkey


Emre Bilgin is a rheumatologist at Hacettepe University where he is doing his MSc on epidemiology. His main interests are rheumatoid arthritis, adult Still’s disease and ANCA-associated vasculitis, aside from his enthusiasm for editorial activities. He is currently working of AI projects and their application into the field of Rheumatology.

Prof. Gerd Burmester 

Universitätsklinikum Charité

Berlin, Germany


Gerd R. Burmester, MD, is Senior Professor of Medicine and Rheumatology in the Department of Rheumatology and Clinical Immunology at the Charité – Universitätsmedizin Berlin, Freie Universität und Humboldt-Universität Berlin and consultant rheumatologist, Division of Rheumatology, MVZ endokrinologikum, partner practice of the Charité.


Professor Burmester earned his medical degree from Hannover Medical School and completed a residency at the Medical School of the University of Erlangen-Nürnberg. He was awarded a postdoctoral fellowship at Rockefeller University in New York and was a visiting scholar at the Hospital for Joint Diseases, Mount Sinai School of Medicine, New York, New York.


Professor Burmester is the recipient of numerous awards, including the Jan van Breemen Medal of the Dutch Society of Rheumatology and the Carol-Nachman Price for Rheumatology.  He serves on several editorial boards, including the Journal of Rheumatology and Clinical Rheumatology, and he is the Editor-in-Chief of RMD Open, official journal of EULAR (European Alliance of Associations for Rheumatology). The author himself of more than 950 original and review articles, Professor Burmester’s research interests include rheumatoid arthritis and psoriatic arthritis, immunotherapy, Lyme borreliosis, cellular activation mechanisms in inflammatory joint diseases, and tissue engineering.


Professor Burmester served as President of the German Society of Rheumatology from 2001-2002. He was a Member of the Executive Committee of EULAR from 2003-2006 acting as Chairman of the Standing Committee on Investigative Rheumatology and became an honorary member of EULAR in 2006. From 2011 – 2013 he served as Treasurer of EULAR, and he served as President of EULAR from 2015 – 201. Since 2017 he is President of the Board of Trustees, FOREUM Foundation for Research in Rheumatology. In 2019 he became Master of the American College of Rheumatology and in 2022 received the Meritorious Service Award in Rheumatology from EULAR. He became honorary member of the German Society of Rheumatology in 2022.

Matteo Caorsi

Dr. Antoni Chan

Royal Berkshire NHS Foundation Trust Reading United Kingdom


Antoni Chan is a Consultant Rheumatologist and Associate Medical Director at the Royal Berkshire NHS Foundation Trust. He did his PhD in immunology Oxford. He has led the Outpatient Clinic Transformation in his hospital. This includes setting up a digital pathway for pathway utilising teleclinics and remote monitoring. He is a Visiting Fellow of the Henley Business School, University of Reading, UK. He works closely within the data, informatics and systems area. He is a member of the Advisory Board of the Blood+ Network which is an international collaboration. He is Clinical Lead for Rheumatology his hospital. His team won the National Axial Spondyloarthritis Society (NASS) Aspiring to Excellence Award. He received the Patient Choice Award for Best Care by a Rheumatologist from NASS in the Houses of Parliament, UK. He is Trustee and Medical Advisory Board Member of NASS.  He is a full member of ASAS and Primary Investigator for clinical trials in his department.

Bart Seppen

Dr. Philip Hamann

North Bristol NHS & University of Bristol

United Kingdom


Dr Philip Hamann is a Consultant Rheumatologist at North Bristol NHS trust and Clinical Lecturer in Rheumatology at the University of Bristol and has been a Fellow of the Turing Institute. His research interests centre on using real world health data to help develop novel methods to monitor and manage individuals with rheumatoid arthritis remotely using remotely captured data. He has worked on data from the BSRBR-RA to investigate the predictors of response to anti-TNF. Dr Hamann conceptualised and developed an award-winning smartphone app and cloud-based software in collaboration with industry partners which allows patients to securely record and report rheumatoid arthritis disease activity using validated patient reported outcomes which is in clinical use in the NHS and has collected over 30,000 ePROMs to date.

Prof. Rachel Knevel

Leiden University Medical Center, Netherlands

Newcastle University, UK


Rachel Knevel is an ass. prof at the Rheumatology Department of the LUMC working as clinician and scientist. During her PhD she studied the genetics of phenotypic characteristics of rheumatoid arthritis. To further specialize in bioinformatics, she was a research fellow at the Raychaudhuri lab at Brigham and Women’s Hospital, Harvard Medical school from 2016-2018. After that, she rejoined prof. Tom Huizinga’s Department of Rheumatology at the Leiden University Medical Centre, where she initiated her research group focusing on early disease differentiation and the identification of homogeneous subsets in patients with rheumatic disease by integrating the “big data” of electronic health records with genetic information

Matteo Caorsi

Dr. Hannah Labinsky

University Hospital Würzburg



Hannah Labinsky is a resident in rheumatology who is now affiliated to the Rheumatology department in Würzburg after starting her residency in Erlangen. Together with Johannes Knitza, she studies the opportunities and barriers of telediagnostics and teletherapy, e.g. using digital therapeutics (DTx), to improve rheumatology care. Her special research interest is axial spondylarthritis (axSpA).

Bart Seppen

Dr. Rebecca Lee

University of Manchester

United Kingdom


Rebecca R. Lee, PhD, is a Chartered Psychologist from the UK with a focus on applied health research in paediatric chronic pain. Her research passion lies in improving the assessment, communication and management of paediatric chronic pain in both research and clinical practice. She has worked on the development and implementation of novel electronic and mobile multi-dimensional pain assessment tools (particularly the ‘My Pain Tracker’ app) for children and young people with relapsing/remitting inflammatory conditions such as juvenile idiopathic arthritis. She has also conducted research exploring healthcare professionals’ pain assessment, communication and management practices, identifying individual/behavioural and contextual/system-level problems and providing solutions for more effective approaches to paediatric chronic pain.

Dr. Philip Riches

University of Edinburgh 

United Kingdom


Dr Philp Riches graduated in medicine and immunology in 1999, and was appointed as consultant rheumatologist in 2010 in NHS Lothian. He completed a PhD in 2015 at Edinburgh University and is now the undergraduate Rheumatology lead and an Honorary Senior Lecturer. His publications include a description of a novel syndrome of osteoporosis in the New England Journal of Medicine, and a trial of supported gout self-management in The Lancet Rheumatology. He has received the Royal College of Physician’s Croom Lectureship, the BMA Foundation Doris Hillier Award, and an Innovation award from the British Society of Rheumatology.

Dr. David Simon

Prof. Daniel H. Solomone

 Brigham and Women’s Hospital

Boston, USA


Daniel H. Solomon, MD, MPH, is a Professor of Medicine and Chief of the Section Clinical Sciences in the Division of Rheumatology at Brigham and Women’s Hospital. He holds the Matthew H. Liang Distinguished Chair in Arthritis and Population Health at the Brigham.  Solomon earned his BA and MD degrees at Yale University, MPH at Harvard University and completed his residency in internal medicine and fellowship in rheumatology at the Brigham.


His early work focused on the safety of NSAIDs and selective COX-2 inhibitors, and he continues to study analgesics. Solomon’s current research focuses on cardiovascular disease in rheumatoid arthritis, and he is the co-Principal Investigator on an NIH funded trial testing the effect of disease-modifying antirheumatic drugs (DMARDs) on cardiovascular disease, also known as the TARGET trial.  He also has several ongoing projects improving implementation of treat to target in rheumatoid arthritis, digital health technologies in rheumatology, and the safety of methotrexate.


He has published over 450 original articles and 100 editorials and book chapters, his articles have been cited over 100,000 times, and he has been PI on numerous NIH, foundation, and industry supported grants.  He is the current Editor in Chief of Arthritis & Rheumatology.  He has chaired the ACR Quality of Care Committee. As well, he has served as the Chair of the FDA Arthritis Advisory Committee. He is also the PI of the VERITY P30 Clinical Research Core at BWH which aims to improve clinical research in rheumatology. He has mentored over 40 trainees and been recognized with mentoring awards from Harvard Medical School, the American College of Rheumatology, and the Brigham. In addition to his investigative achievements, Solomon has a busy clinical practice and has played a special role in helping the Hispanic community and been instrumental in advancing the collaborative clinical Cardiovascular in Rheumatology Medicine practice at BWH.

Sandra Hauser-Ulrich

Maya Zlatanova

FindMeCure ltd

United Kingdom


Maya Zlatanova (hyperlink to LI profile) is the CEO and co-founder of FindMeCure (patient navigation platform) and TrialHub (data-intelligence platform for clinical trials). Her team and Maya are on a mission to bringing clinical research closer to patients by improving the way we design and conduct clinical trials according to patients needs and expectations. Maya is also the host of the podcast Trials with Maya Z where different experts discuss the challenges of clinical trials and how we can overcome them.  

Matthias Diener

Digital Rheuma Lab

Berlin, Germany


Matthias Diener is Co-Founder of the berlin-based Digital Health startup Digital Rheuma Lab and a Business Lead at Wellster Healthtech Group, Germanys biggest telemedicine provider.
Against the background of being affected himself as a patient with a rheumatic disease, Matthias engages in qualitative research on market environment  as well as the development of digital products and patient communities, combining his professional background in tech startups with his experience as a patient.
His overall vision is to improve rheumatology care with the patient at the center of digital solutions.

Dr. Judith Safford

SCQM Foundation

Zürich, Switzerland


Judith Safford trained as an economist (Dr. rer. pol) in Germany and has dedicated her professional life to excellence in non-profit management. Affected by spondyloarthritis and colitis since early adulthood, she is also a cancer survivor. Her special interest is the involvement of patients in healthcare, particularly through their participation in medical research. She is co-founder and President of the RheumaCura Foundation, which advocates for people-centred arthritis research. Furthermore, she is executive director of the SCQM foundation (Swiss national registry of inflammatory rheumatic diseases) and engages as a patient expert in research projects, including an SNSF funded project at the University Hospital of Zürich. She is a Fellow of the Sciana health leaders’ network and writes a blog at Exercise is essential to her health management, so she sneaks off to the Alps whenever time permits to tramp along a snowy mountain slope or scamper up a rock wall.


Dr. David Simon

Dr. Julie Horan


United Kingdom


Julie Horan is a real-world evidence expert at UCB focusing on digital care transformation. She is merging her medical background with knowledge and experience in digital health and patient-generated health data. Her current work explores development, implementation and evaluation of patient-centred health technology collecting real-world data to help patients and clinicians better manage chronic diseases.

Sandra Hauser-Ulrich

Dr. Diego Benavent

Hospital Universitario La Paz



Diego Benavent is a consultant rheumatologist at Hospital Universitario La Paz in Madrid, where he is currently completing his PhD on axial spondyloarthritis. Additionally, he works as a Medical Expert at Savana, a company focused on applying artificial intelligence and natural language processing to medicine. In addition to his work on spondyloarthritis, Diego has participated in various healthcare technology projects related to patient-reported outcomes and patient management strategies. He is a member of ASAS and is the current chair of the Newsletter Sub-Committee in EMEUNET.

Dr. Martin Welcker

 MVZ für Rheumatologie



Martin Welcker studied at the Ludwig Maximilian University in Munich.
As a member of the German National Academic Foundation, he received a scholarship abroad at the Institut Pasteur (Dept. Immunogéntétique in Paris, France) during a phase in which the PCR technique was established.
He completed his PhD on the topic of GSB knee prosthesis under Prof. Dr. F. W. Hagena.
During his postgraduate training he worked at the Rheumatism Unit of the Ludwig-Maximilians-University, the Städt. Hospital Bogenhausen and the Technical University of Munich. He completed this with the recognition as a specialist in internal medicine (1996) and the recognition of the sub-specialty of rheumatology (97).
In addition, he acquired the additional qualifications of chiropractic and osteology DVO.
After working as a senior physician at the Rheumazentrum Oberammergau and at the Städt. Hospital Lainz (Vienna, CA Prof. J. Smolen), he took over a practice on the outskirts of Munich in 2004, originally run by a general internist.
With the goal of improving rheumatology care and based on his specialty, a rheumatology focus practice quickly emerged, which has been established as an MVZ for rheumatology since 2015.
In 2020, the MVZ was approved for ASV Rheumatology. In addition to the guideline-compliant “treat to target” concept in patient care, the focus of activities is on process optimization with digitalization of medicine, in order to allow more time for the patient, among other things, in the conversation in the sense of human medicine.
Thus his activities in the executive committee of the professional association of German rheumatologists and the cooperation in the AG IT/Digitalisierung of the BDRH as well as the cooperation in the AG Digitales of the DGRH counted to his tasks. Dr. Welcker is also involved in numerous national and international lectures and publications.


Prof. BJF (Bart) van den Bemt

Sint Maartenskliniek and the Radboud University Medical Center Nijmegen, The Netherlands


Professor Bart van den Bemt is clinical pharmacist, clinical pharmacologist and senior clinical scientist at the departments of Pharmacy in the Sint Maartenskliniek and the Radboud University Medical Center in Nijmegen, The Netherlands. Bart is medical manager of the in- and outpatient pharmacy of the Sint Maartenskliniek and head of Research and Innovation of the same hospital.


Due to his professional experiences as community-, clinical-, outpatient- and formula-pharmacist Bart has extensive experience of pharmacy practice, the development of (digital) pharmaceutical care programs and development of educational programs. Bart also founded a new Dutch bachelor course Pharmaceutical Consultant and is member of several committees/boards on pharmacotherapy, education, pharmaceutical care and outpatient pharmacy. Bart was president of the European Society of Clinical Pharmacy and vice-president of the Dutch Association of Hospital Pharmacy..


Bart’s research interests are focused on Personalized Pharmaceutical Care including medication adherence, e-health, medication review, therapeutic drug monitoring of biologicals, inflammatory pain, transitional care and medication wastage.



Prof. Christian Dejaco

Medical University Graz



Christian Dejaco has studied Medicine and done a PhD in Innsbruck, Austria. He is currently the head of the Department of Rheumatology of the South Tyrol Health Trust and an Associate Professor at the Medical University of Graz.


Dr. Paco M. J. Welsig

University Medical Center Utrecht

The Netherlands


Paco M.J. Welsing, PhD is a clinical Epidemiologist and HTA (Health Technology Assessment) expert at the department of Rheumatology & Clinical Epidemiology of the University Medical Center Utrecht (The Netherlands). He was trained in Biomedical Health Sciences at the Radboud University Nijmegen, The Netherlands and received a Master of Science (MSc) in Epidemiology and in HTA in 2000. Subsequently he started working at the department of Rheumatology of the Radboud University Medical Center where he obtained his doctorate in 2005 mainly on clinical and health economic studies on the use of TNF-inhibiting drugs for the treatment of rheumatoid arthritis.


Paco has experience in an academic setting, as researcher and teacher (Epidemiology, Biostatistics, Evidence Based Medicine and HTA), as well as in a pharmaceutical setting, as Manager Outcomes Research at Pfizer. His research interest lies in the optimal application of health interventions in daily clinical practice. Specifically prediction based decision aid using machine learning techniques and applications for implementation of decision aids. 

Apart from performing research himself he also has experience with consulting on study design and statistical analysis, writing of protocols and as a member of the Medical Ethical Review Board (methodologist) and Editorial Board (methodological/statistical adviser) for medical journals. Although he has experience in different therapeutic areas, most experience is in the field of Rheumatology.

Prof. Sebastian Kuhn

Philipps University Marburg



Univ.-Prof. Dr. med. Sebastian Kuhn, MME

– W3 Professor for Digital Medicine at the Philipps University of Marburg and Director of the Institute for Digital Medicine University Hospital Giessen-Marburg 
– Orthopedic and Trauma Surgeron 

Main areas of activity in the context of digital transformation:

– Development, evaluation and process implementation of Digital Health Apps into medical treatment workflows and digitally-enabled patient journeys.
– Augmentation of physician action with AI-based clinical decision support systems
– Qualification in education, training and continuing education for physicians and health care professionals in the context of the digital transformation of medicine

– Chairman of the Working Group “Digital Competencies” of the “Standing Committee of European Doctors / Comité Permanent des Médecins Européens” and Member of the Working Group “Digital Health” 
– Member of the Committee of the German Medical Association “Digitalization of Health Care” and “Medical Education and University Medicine” (2019-2023)
– Chairman of the expert opinion board medicine “Trusted Health Apps”

Sponsors & Partners 2023

Main Sponsor:.

Further Sponsors:

This course is endorsed by:

Digital Rheumatology Research Award


The award will be given to scientists for innovative master theses, dissertations, or publications in the field of digital rheumatology.

The research price includes:

  • 500 Euros
  • 10 minute oral presentation and award ceremony during the Digital Rheumatology Day in Berlin
  • A small article will be published at the Digital Rheumatology Network and its social media channels.

General conditions:

  • At the time of application, the publication/thesis/dissertation should not be more than two years old.
  • Papers must have been published in an international peer-reviewed recognized journal as original work and applicant must be first or last author.
  • Thesis or dissertations must already have been accepted or published at a university.

The winner will be selected by the board members of the Digital Rheumatology Network based on the clinical relevance, originality and scientific merit.

Please send us the following documents in English in one pdf file:

  • A curriculum vitae
  • A short abstract summary (max. 300 words)
  • Proof of acceptance as thesis, dissertation, or publication

Please send your pdf application until 28 February 2023 to Sina Reis-Balikcioglu:

All participants can join the meeting free of charge and can present their work as an E-Poster.

Pitching Event 

We are happy to announce a pitching event again. The winner will be presented during the 5th Digital Rheumatology Day on May 6, 2023.

Who can join:

Applications can be submitted by providers and developers of digital solutions that (could) improve quality of care in rheumatology.

Benefit for all participants:

  • After approval by the Advisory Board of the Digital Rheumatology Network, all submitted videos will be published on and announced on the channels (LinkedIn, Twitter) of the Digital Rheumatology Network.
  • Free entrance to the 5th Digital Rheumatology Day

The winner price includes:

  • 3min winner video will be presented during the 5th Digital Rheumatology Day
  • 5 -10 min Q & A with the audience to receive some valuable feedback
  • Award ceremony
  • Announcement as winner on the channels (Newsletter, LinkedIn, Twitter) of the network

How to submit:

Please send your 3min elevator pitch video until 15 April 2023 to

Here you can find the winner video of the pitching event in 2022: Winner of the Pitching Event during the 4th Digital Rheumatology Day – Digital Rheumatology Network



General Information


Seminaris CampusHotel Berlin

Takustraße 39
14195 Berlin

Room Domus at the Conference Center 2nd floor



Who should attend?

The Digital Rheumatology Day connects leading experts from a wide variety of disciplines like physicians (Rheumatologists, Radiologists, Rehabilitation, Internal Medicine, Immunologists), patients, pharma and MedTech industry, Health IT companies, associations, consultants and academia as well as research centers to discover new innovative practices.


The event language is English.


Comeed – Medical Conferences, Meetings & Education        Sina Reis-Balikcioglu


There are three ways to join the meeting:

1. on site in Berlin

2. online on Friday and on-site on Saturday

3. online on Friday only.

All participants will receive the recordings of the event afterwards.  (subject to the approval of the speakers)

Catering is provided for all participants on site.